HYPD
Price
$10.79
Change
-$0.77 (-6.66%)
Updated
Jul 9 closing price
Capitalization
55.08M
VACBF
Price
$0.19
Change
-$0.01 (-5.00%)
Updated
Jul 1 closing price
Capitalization
58.44M
Interact to see
Advertisement

HYPD vs VACBF

Header iconHYPD vs VACBF Comparison
Open Charts HYPD vs VACBFBanner chart's image
Hyperion DeFi
Price$10.79
Change-$0.77 (-6.66%)
Volume$934.25K
Capitalization55.08M
NYKODE THERAPEUTICS AS
Price$0.19
Change-$0.01 (-5.00%)
Volume$200
Capitalization58.44M
HYPD vs VACBF Comparison Chart in %
Loading...
HYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VACBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HYPD vs. VACBF commentary
Jul 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HYPD is a StrongBuy and VACBF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 10, 2025
Stock price -- (HYPD: $10.79 vs. VACBF: $0.19)
Brand notoriety: HYPD and VACBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HYPD: 15% vs. VACBF: 8%
Market capitalization -- HYPD: $55.08M vs. VACBF: $58.44M
HYPD [@Biotechnology] is valued at $55.08M. VACBF’s [@Biotechnology] market capitalization is $58.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HYPD’s FA Score shows that 0 FA rating(s) are green whileVACBF’s FA Score has 1 green FA rating(s).

  • HYPD’s FA Score: 0 green, 5 red.
  • VACBF’s FA Score: 1 green, 4 red.
According to our system of comparison, HYPD is a better buy in the long-term than VACBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HYPD’s TA Score shows that 2 TA indicator(s) are bullish while VACBF’s TA Score has 1 bullish TA indicator(s).

  • HYPD’s TA Score: 2 bullish, 4 bearish.
  • VACBF’s TA Score: 1 bullish, 2 bearish.
According to our system of comparison, VACBF is a better buy in the short-term than HYPD.

Price Growth

HYPD (@Biotechnology) experienced а -31.80% price change this week, while VACBF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +12.58%. For the same industry, the average monthly price growth was +16.60%, and the average quarterly price growth was +18.46%.

Reported Earning Dates

HYPD is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Biotechnology (+12.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VACBF($58.4M) has a higher market cap than HYPD($55.1M). HYPD YTD gains are higher at: 7290.411 vs. VACBF (-19.975). VACBF has higher annual earnings (EBITDA): -30.2M vs. HYPD (-39.11M). VACBF has higher revenues than HYPD: VACBF (7.85M) vs HYPD (67.1K).
HYPDVACBFHYPD / VACBF
Capitalization55.1M58.4M94%
EBITDA-39.11M-30.2M130%
Gain YTD7290.411-19.975-36,498%
P/E RatioN/AN/A-
Revenue67.1K7.85M1%
Total CashN/A106M-
Total DebtN/A3.28M-
FUNDAMENTALS RATINGS
HYPD: Fundamental Ratings
HYPD
OUTLOOK RATING
1..100
32
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
40
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HYPDVACBF
RSI
ODDS (%)
Bearish Trend 1 day ago
85%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
33%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
17%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 2 days ago
37%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 2 days ago
24%
Advances
ODDS (%)
Bullish Trend 8 days ago
80%
N/A
Declines
ODDS (%)
Bearish Trend 20 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 2 days ago
12%
View a ticker or compare two or three
Interact to see
Advertisement
HYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VACBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CBUMY49.5023.78
+92.49%
China National Buildings Material
GCAAF31.79N/A
N/A
Guardian Capital Group Ltd.
HBSI35.00N/A
N/A
Highlands Bankshares, Inc.
NDATF0.01N/A
N/A
NDATALYZE CORP.
AIPUF1.31N/A
N/A
Airports of Thailand Public Co., Ltd.

HYPD and

Correlation & Price change

A.I.dvisor indicates that over the last year, HYPD has been loosely correlated with CTXR. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if HYPD jumps, then CTXR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HYPD
1D Price
Change %
HYPD100%
-6.66%
CTXR - HYPD
37%
Loosely correlated
-8.53%
QNTM - HYPD
35%
Loosely correlated
+1.75%
INKT - HYPD
34%
Loosely correlated
+1.13%
VACBF - HYPD
32%
Poorly correlated
N/A
ACXP - HYPD
30%
Poorly correlated
+2.35%
More

VACBF and

Correlation & Price change

A.I.dvisor tells us that VACBF and HYPD have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VACBF and HYPD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VACBF
1D Price
Change %
VACBF100%
N/A
HYPD - VACBF
32%
Poorly correlated
-6.66%
SPHRY - VACBF
27%
Poorly correlated
-1.90%
RVPH - VACBF
22%
Poorly correlated
+3.53%
ZBIO - VACBF
21%
Poorly correlated
+5.22%
BPTSY - VACBF
20%
Poorly correlated
N/A
More